NCT02962375 (PEP) is a NA clinical trial of Active in Healthy, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Who is sponsoring NCT02962375?

NCT02962375 is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

What drugs are being tested in NCT02962375?

Interventions in NCT02962375: Active, Control.

Is NCT02962375 still recruiting?

NCT02962375 is currently completed. Last updated 27 January 2021.

Last reviewed 2021-01-27 · How we verify

NCT02962375: PEP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Orange Pomace Fiber on Glycemic Response

Completed NA Last updated 27 January 2021

What this trial tests

NA trial testing Active in Healthy in 12 participants. Completed in 18 September 2017.

Timeline

22 November 2016

Primary endpoint
14 February 2017

18 September 2017

Quick facts

Lead sponsor	Clinical Nutrition Research Center, Illinois Institute of Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	basic science
Enrollment	12
Start date	22 November 2016
Primary completion	14 February 2017
Estimated completion	18 September 2017
Sites	1 location across United States

Drugs / interventions tested

Active (active) — full drug profile →
Control

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Clinical Nutrition Research Center, Illinois Institute of Technology — full company profile →

Who can join

Adults 20 to 45, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Primary object is to determine if 100% orange juice with enzyme-treated orange pomace fiber compared to a 100% orange juice will reduce 2 hr glycemic response as measured by glucose area under the curve. Secondary object is to assess if 100% orange juice with enzyme-treated orange pomace fiber compared to a 100% orange juice will reduce 2 hr insulin iAUC response.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Enzyme-treated orange pomace alters acute glycemic response to orange juice.
Huang Y, Park E, Replogle R, Boileau T, et al · · 2019 · cited 5× · PMID 31462629 · DOI 10.1038/s41387-019-0091-z
Upcycled Orange Peel Ingredients for Gastrointestinal and Cardiometabolic Health: A Scoping Review and Market Perspectives.
Vilas-Boas AA, Correia M, Campos DA, Pintado M. · · 2026 · PMID 41978175 · DOI 10.3390/nu18071126

Verify or expand the search:

Other trials of Active

Trials testing the same drug.

NCT07109713 — The Effect Cranberry-Based Products on the Female Microbiome · NA · recruiting
NCT06663865 — Investigating the Effects of Dairy Phospholipids on Sleep and Daytime Function in Healthy Adults. · NA · not yet recruiting
NCT06102174 — A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and Children Wi · Phase 1 · terminated
NCT06109922 — Investigating the Effects of Dietary Phospholipids on Stress Reactivity and Recovery · NA · completed
NCT06107075 — Investigating the Effects of Dietary Phospholipids on Measures of Human Brain Health and Psychological Wellbeing · NA · recruiting

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Clinical Nutrition Research Center, Illinois Institute of Technology trials

Trials by the same sponsor.

NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
NCT05898217 — Vitamin and Mineral Absorption From Milk and PBMAs · NA · active not recruiting
NCT05892328 — Watermelon Dose Response Blood Pressure Study · NA · active not recruiting
NCT05601635 — ButyraGen™, Short Chain Fatty Acids and Gut Microbiome · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02962375 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Clinical Nutrition Research Center, Illinois Institute of Technology
Last refreshed: 27 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02962375.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing